US FDA declines to approve Scholar Rock's muscle weakness drug
Group 1 - The U.S. Food and Drug Administration (FDA) has declined to approve Scholar Rock's drug for a rare neuromuscular disease [1] - The rejection is attributed to issues at a third-party manufacturing facility [1]